CD8A and infection: Likewise, HLA-B*0702 ifnar1−/− mice immunized with an NS3 vaccine that was designed to generate a CD8+ T cell response rather than a neutralizing antibody response were protected from death or fetal growth restriction, with decreased viral loads in the serum, brain, and liver tissue three days post-infection.